Stephen Olson

Company: AstraZeneca

Job title: Senior Director - Medical, Early Clinical Development, Cardiovascular, Renal & Metabolism

Seminars:

APOL1-Mediated Kidney Disease (AMKD): Pathophysiology & Promise of Antisense Oligonucleotide (ASO) Therapy 9:00 am

Discussing multiple proposed mechanisms of disease for AMKD Sharing Phase 1 data for APOL1 ASO Therapy Outlining AMKD Phase 2 study design challenges for APOL1 ASO TherapyRead more

day: Conference Day Two